A RANDOMIZED SINGLE-CENTER PHASE-III TRIAL WITH PIPERACILLIN SULBACTAM AND CEFTAZIDIME AS FIRST-LINE TREATMENT FOR 103 FEBRILE EPISODES IN PATIENTS WITH SEVERE NEUTROPENIA/
T. Lange et al., A RANDOMIZED SINGLE-CENTER PHASE-III TRIAL WITH PIPERACILLIN SULBACTAM AND CEFTAZIDIME AS FIRST-LINE TREATMENT FOR 103 FEBRILE EPISODES IN PATIENTS WITH SEVERE NEUTROPENIA/, British Journal of Haematology, 102(1), 1998, pp. 94-95